Informed consent for prostate-specific antigen screening

Urology

Volumn 61, Issue 1, 2003, Pages 13-14

  Carter, H Ballentine ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BLOOD ANALYSIS; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COMORBIDITY; EDITORIAL; FAMILY HISTORY; HUMAN; INFORMED CONSENT; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; RACE DIFFERENCE; RECTUM; SCREENING TEST;

HEALTH CARE AND PUBLIC HEALTH; PROFESSIONAL PATIENT RELATIONSHIP;

COMMUNICATION; HUMANS; INFORMED CONSENT; MALE; MASS SCREENING; PHYSICIAN-PATIENT RELATIONS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0037260161     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02009-5     Document Type: Editorial

References (11)

1. Gann P.H. Interpreting trends in prostate cancer incidence and mortality. Epidemiology. 8:1997;117-120.
2. Etzioni R., Berry K.M., Legler J.M., et al. Prostate-specific antigen testing in black and white men an analysis of medicare claims from 1991-1998. Urology. 59:2002;251-255.
3. Dunn A.S., Shridharani K.V., Lou W., et al. Physician-patient discussions of controversial cancer screening tests. Am J Prev Med. 20:2001;130-134.
4. Giesen D. The patient's right to know - a comparative law perspective. Med Law. 12:1993;553-565.
5. Chan E.C., Sulmasy D.P. What should men know about prostate-specific antigen screening before giving informed consent? Am J Med. 105:1998;266-274.
6. Thompson I., Carroll P., Coley C., et al. Prostate-specific antigen (PSA) best practice policy. Oncology. 14:2000;267-286.
7. Smith R.A., Mettlin C.J., Davis K.J., et al. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin. 50:2000;34-49.
8. Coley C.M., Barry M.J., Mulley A.G. Clinical guideline Part III. Screening for prostate cancer. Ann Intern Med. 126:1997;480-484.
9. Newschaffer C.J., Otani K., McDonald M.K., et al. Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort. J Natl Cancer Inst. 92:2000;613-621.
10. Ries LAG, Eisner MP, Kosary CL, et al: (Eds): SEER Cancer Statistics Review, 1973-1999. Bethesda, National Cancer Institute, 2002.
11. Gronberg H., Damber L., Jonson H., et al. Prostate cancer mortality in northern Sweden, with special reference to tumor grade and patient age. Urology. 49:1997;374-378.